Susann Ashley O'banion, NP | |
810 N 22nd St, Blair, NE 68008-1128 | |
(402) 426-2182 | |
(402) 426-1180 |
Full Name | Susann Ashley O'banion |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 7 Years |
Location | 810 N 22nd St, Blair, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972026995 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | A112488 (Iowa) | Secondary |
363LF0000X | Nurse Practitioner - Family | 112283 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Community Hospital Mch & Health System | Blair, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Community Hospital Corporation | 0749190775 | 19 |
News Archive
The oldest segment of Japan's population will likely be the hardest hit as a result of the recent earthquake and subsequent tsunami, based on data from previous catastrophic events. Approximately 23 percent of Japanese citizens currently are age 65 and above.
In a comprehensive study released today by Population Action International (PAI) - an independent policy and research organization based in Washington, D.C. - the United States ranks 16th and receives a "C" on a list of 21 donor countries graded according to their financial and political support for international reproductive health and population programs.
Women whose first pregnancy ended in infant death are significantly more likely to have a subsequent stillbirth finds new research published in BJOG: An International Journal of Obstetrics and Gynaecology.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere's Convertible Promissory Note to May 26, 2010.
A team led by scientists at The Scripps Research Institute (TSRI) has found how to boost or inhibit a gene-silencing mechanism that normally serves as a major controller of cells' activities. The discovery could lead to a powerful new class of drugs against viral infections, cancers and other diseases.
› Verified 8 days ago
Entity Name | Memorial Community Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265408819 PECOS PAC ID: 0749190775 Enrollment ID: O20040202001065 |
News Archive
The oldest segment of Japan's population will likely be the hardest hit as a result of the recent earthquake and subsequent tsunami, based on data from previous catastrophic events. Approximately 23 percent of Japanese citizens currently are age 65 and above.
In a comprehensive study released today by Population Action International (PAI) - an independent policy and research organization based in Washington, D.C. - the United States ranks 16th and receives a "C" on a list of 21 donor countries graded according to their financial and political support for international reproductive health and population programs.
Women whose first pregnancy ended in infant death are significantly more likely to have a subsequent stillbirth finds new research published in BJOG: An International Journal of Obstetrics and Gynaecology.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere's Convertible Promissory Note to May 26, 2010.
A team led by scientists at The Scripps Research Institute (TSRI) has found how to boost or inhibit a gene-silencing mechanism that normally serves as a major controller of cells' activities. The discovery could lead to a powerful new class of drugs against viral infections, cancers and other diseases.
› Verified 8 days ago
Entity Name | Alegent Creighton Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
The oldest segment of Japan's population will likely be the hardest hit as a result of the recent earthquake and subsequent tsunami, based on data from previous catastrophic events. Approximately 23 percent of Japanese citizens currently are age 65 and above.
In a comprehensive study released today by Population Action International (PAI) - an independent policy and research organization based in Washington, D.C. - the United States ranks 16th and receives a "C" on a list of 21 donor countries graded according to their financial and political support for international reproductive health and population programs.
Women whose first pregnancy ended in infant death are significantly more likely to have a subsequent stillbirth finds new research published in BJOG: An International Journal of Obstetrics and Gynaecology.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere's Convertible Promissory Note to May 26, 2010.
A team led by scientists at The Scripps Research Institute (TSRI) has found how to boost or inhibit a gene-silencing mechanism that normally serves as a major controller of cells' activities. The discovery could lead to a powerful new class of drugs against viral infections, cancers and other diseases.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Susann Ashley O'banion, NP 810 N 22nd St, Blair, NE 68008-1128 Ph: (402) 426-2182 | Susann Ashley O'banion, NP 810 N 22nd St, Blair, NE 68008-1128 Ph: (402) 426-2182 |
News Archive
The oldest segment of Japan's population will likely be the hardest hit as a result of the recent earthquake and subsequent tsunami, based on data from previous catastrophic events. Approximately 23 percent of Japanese citizens currently are age 65 and above.
In a comprehensive study released today by Population Action International (PAI) - an independent policy and research organization based in Washington, D.C. - the United States ranks 16th and receives a "C" on a list of 21 donor countries graded according to their financial and political support for international reproductive health and population programs.
Women whose first pregnancy ended in infant death are significantly more likely to have a subsequent stillbirth finds new research published in BJOG: An International Journal of Obstetrics and Gynaecology.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere's Convertible Promissory Note to May 26, 2010.
A team led by scientists at The Scripps Research Institute (TSRI) has found how to boost or inhibit a gene-silencing mechanism that normally serves as a major controller of cells' activities. The discovery could lead to a powerful new class of drugs against viral infections, cancers and other diseases.
› Verified 8 days ago
Mrs. Angelica Monique Griffiths, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 S 19th St, Blair, NE 68008 Phone: 402-426-2210 |